Privia Health Group Inc
NASDAQ:PRVA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
18.86
26.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Privia Health Group Inc
Privia Health Group Inc. is a compelling tale of innovation in the healthcare space, driven by its unique approach to physician enablement. Founded on the principle of enhancing the operational efficiency of medical practices, Privia Health partners with physicians to help them deliver high-quality care while navigating the complexities of modern healthcare systems. By providing a robust technology platform alongside a comprehensive suite of clinical, financial, and operational services, Privia empowers doctors to maintain their independence while benefiting from the support and scale typically enjoyed by larger healthcare organizations. This model not only enhances patient care but also aligns with value-based care initiatives by focusing on outcomes rather than solely on the volume of services provided.
The company's revenue engine is fueled by several streams. Primarily, Privia generates earnings through management service agreements with the practices it partners with. These agreements involve sharing savings that result from improved care coordination and operational efficiencies, part of which are attributed to the physicians and part retained by Privia. Additionally, the organization benefits from its participation in value-based care contracts, where performance metrics tied to quality and cost can lead to shared savings arrangements with payers. This alignment of interests between Privia, the physicians, and the payers forms a sustainable business model that prioritizes both profitability and improved patient outcomes, setting a new benchmark in the healthcare landscape.
Privia Health Group Inc. is a compelling tale of innovation in the healthcare space, driven by its unique approach to physician enablement. Founded on the principle of enhancing the operational efficiency of medical practices, Privia Health partners with physicians to help them deliver high-quality care while navigating the complexities of modern healthcare systems. By providing a robust technology platform alongside a comprehensive suite of clinical, financial, and operational services, Privia empowers doctors to maintain their independence while benefiting from the support and scale typically enjoyed by larger healthcare organizations. This model not only enhances patient care but also aligns with value-based care initiatives by focusing on outcomes rather than solely on the volume of services provided.
The company's revenue engine is fueled by several streams. Primarily, Privia generates earnings through management service agreements with the practices it partners with. These agreements involve sharing savings that result from improved care coordination and operational efficiencies, part of which are attributed to the physicians and part retained by Privia. Additionally, the organization benefits from its participation in value-based care contracts, where performance metrics tied to quality and cost can lead to shared savings arrangements with payers. This alignment of interests between Privia, the physicians, and the payers forms a sustainable business model that prioritizes both profitability and improved patient outcomes, setting a new benchmark in the healthcare landscape.
Strong Quarter: Privia Health reported robust Q3 results, with significant revenue and margin growth driven by new provider additions and strong value-based care performance.
Guidance Raised: Management increased full-year 2025 guidance above previous ranges, citing continued momentum and visibility into 2026.
Margin Expansion: Adjusted EBITDA margin as a percentage of care margin expanded by 720 basis points year-over-year, reaching 30.5%.
Practice Collections: Practice collections grew 27.1% year-over-year in Q3, outpacing provider growth and reflecting strong utilization trends and new market contributions.
Evolent Acquisition: Privia is acquiring Evolent Health’s ACO business, adding over 120,000 attributed lives and expanding to six new states; the deal is expected to close by year-end and contribute to EBITDA in 2026.
Diversified Value-Based Book: Growth in attributed lives was broad-based across commercial, Medicare, and Medicaid, each up over 12% year-over-year.
Cash Position: Pro forma cash at quarter-end was $409.9 million with no debt, supporting continued business development and potential M&A.
Capitated MA Business: The Medicare Advantage capitation book remains small but profitable; management remains cautious about growing this segment given industry headwinds.